Patent details

Basic Information

Publication number:

EP2083858

PCT Application Number:

PCT/US/2007/022193

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP078528262

PCT Publication Number:

WO/2008/051424

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

HUMAN IMMUNE THERAPIES USING A CD27 AGONIST ALONE OR IN COMBINATION WITH OTHER IMMUNE MODULATORS

French Title of Invention:

THÉRAPIES IMMUNES HUMAINES UTILISANT UN AGONISTE CD27 SEUL OU EN COMBINAISON AVEC D'AUTRES MODULATEURS IMMUNS

German Title of Invention:

HUMANE IMMUNTHERAPIEN MIT EINEM CD27-AGONISTEN ALLEIN ODER IN KOMBINATION MIT ANDEREN IMMUNMODULATOREN

SPC Number:

Dates

Filing date:

18/10/2007

Grant date:

11/12/2013

EP Publication Date:

11/12/2013

PCT Publication Date:

02/05/2008

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/08/2009

EP B1 Publication Date:

11/12/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/10/2014

Expiration date:

18/10/2027

Renunciation date:

Revocation date:

24/11/2021

Annulment date:

Owner

From:

18/10/2007

 

 

Name:

University Of Southampton

Address:

University Road, Highfield SO17 1BJ, United Kingdom (GB)

Inventor

1

Name:

TUTT Alison Louise

Address:

United Kingdom (GB)

2

Name:

AL-SHAMKHANI Aymen

Address:

United Kingdom (GB)

3

Name:

GLENNIE Martin John

Address:

United Kingdom (GB)

Priority

Priority Number:

0620894

Priority Date:

20/10/2006

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

C07K 16/28;

Publication

European Patent Bulletin

Issue number:

202218

Publication date:

04/05/2022

Description:

Revocation of the European patent

Filing date	Document type	Number of pages